Latest Breaking News On - Joint warfighter medical research - Page 1 : comparemela.com

Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update

Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJoyce allaireDeborah birxPierre kymeWarfighter medical research programPharmaceuticals incUs department of defenseArmata pharmaceuticals incTechnology enterprise consortiumLifesci advisorsDefense health agencyDepartment of defensePrnewswire armata pharmaceuticals incRecent developmentsClinical studyNorth american cystic fibrosis conference

Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a diSArm Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus

Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a diSArm Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJoyce allaireMina pastagiaPierre kymeDeborah birxDefense health agencyNaval medical researchData review committeeDepartment of defenseArmata pharmaceuticals incLifesci advisorsUs department of defenseTechnology enterprise consortiumWarfighter medical research programPrnewswire armata pharmaceuticals incChief executive officer

I3R Neural Prosthesis Project Gets $5M Grant From Defense Department

The grant will add Walter Reed National Military Medical Center in Bethesda, Maryland, as a second clinical trial site.

United statesWalter reedPaul pasquinaErika petersenDrug administrationWalter reed national military medical centerWarfighter medical research programWalter reed national medical centerUs department of defenseUniformed services universityArkansa instituteInnovative researchHuman researchJoint warfighter medical research

Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update

/PRNewswire/ Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific.

United statesFrance generalPierre kymeDeborah birxDeborahl birxJoyce allairePrnewswire armata pharmaceuticals incArmata pharmaceuticals incDefense health agencyTechnology enterprise consortiumWarfighter medical research programUs department of defenseLifesci advisorsRecent developmentsInnoviva boardChief executive

Armata Pharmaceuticals Announces First Quarter 2023 Results and Provides Corporate Update

/PRNewswire/ Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific.

United statesPierre kymeJoyce allaireBrian varnumArmata pharmaceuticals incDefense health agencyInnoviva incTechnology enterprise consortiumPrnewswire armata pharmaceuticals incInnoviva strategic opportunitiesUs department of defenseLifesci advisorsWarfighter medical research programRecent developmentsChief executive officerMedical technology enterprise consortium